Twist Bioscience Corp (TWST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Twist Bioscience Corp (TWST) has a cash flow conversion efficiency ratio of -0.039x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.56 Million) by net assets ($455.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TWST equity to assets ratio to measure how much of total assets are equity-financed.
Twist Bioscience Corp - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Twist Bioscience Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check TWST cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Twist Bioscience Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Twist Bioscience Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FLSmidth & Co.
CO:FLS
|
0.000x |
|
Huaxin Cement Co Ltd A
SHG:600801
|
0.092x |
|
Silicon Motion Technology
NASDAQ:SIMO
|
0.002x |
|
Grupo Aeroportuario del Centro Norte S.A.B. de C.V.
F:G7A
|
0.137x |
|
Pangang Group Vanadium Titanium & Resources Co Ltd
SHE:000629
|
0.031x |
|
Anhui Yingjia Distillery Co Ltd
SHG:603198
|
0.047x |
|
LEG Immobilien SE
XETRA:LEG
|
0.017x |
|
PT Alamtri Resources Indonesia Tbk
JK:ADRO
|
0.051x |
Annual Cash Flow Conversion Efficiency for Twist Bioscience Corp (2016–2025)
The table below shows the annual cash flow conversion efficiency of Twist Bioscience Corp from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see TWST market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $472.96 Million | $-47.63 Million | -0.101x | +25.73% |
| 2024-09-30 | $472.69 Million | $-64.09 Million | -0.136x | +40.67% |
| 2023-09-30 | $623.43 Million | $-142.47 Million | -0.229x | -45.03% |
| 2022-09-30 | $789.38 Million | $-124.39 Million | -0.158x | +18.46% |
| 2021-09-30 | $580.82 Million | $-112.24 Million | -0.193x | +54.32% |
| 2020-09-30 | $336.26 Million | $-142.25 Million | -0.423x | +26.84% |
| 2019-09-30 | $152.08 Million | $-87.94 Million | -0.578x | -276.03% |
| 2018-09-30 | $-201.42 Million | $-66.16 Million | 0.328x | -14.61% |
| 2017-09-30 | $-133.36 Million | $-51.30 Million | 0.385x | -23.63% |
| 2016-09-30 | $-76.61 Million | $-38.59 Million | 0.504x | -- |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more